{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T03:17:59Z","timestamp":1762917479104},"reference-count":28,"publisher":"Elsevier BV","issue":"42","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,13]],"date-time":"2014-09-13T00:00:00Z","timestamp":1410566400000},"content-version":"vor","delay-in-days":347,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico (CNPq)"},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior (CAPES)"},{"name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais (FAPEMIG)"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/j.vaccine.2013.08.023","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T13:28:03Z","timestamp":1377005283000},"page":"4706-4709","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Neutralizing antibodies associated with exposure factors to Orthopoxvirus in laboratory workers"],"prefix":"10.1016","volume":"31","author":[{"given":"Galileu Barbosa","family":"Costa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth Castro","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giliane","family":"de Souza Trindade","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2013.08.023_bib0005","series-title":"Fields virology","first-page":"2906","article-title":"Poxviridae: the viruses and their replication","author":"Moss","year":"2007"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0010","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.vetmic.2009.08.026","article-title":"Zoonotic poxviruses","volume":"140","author":"Essbauer","year":"2010","journal-title":"Vet Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0015","series-title":"Smallpox and its erradication","author":"Fenner","year":"1988"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0020","series-title":"Fields virology","first-page":"2947","article-title":"Poxviruses","author":"Damon","year":"2007"},{"issue":"1","key":"10.1016\/j.vaccine.2013.08.023_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.antiviral.2009.06.006","article-title":"Vaccinia virus vaccines: past, present and future","volume":"84","author":"Jacobs","year":"2009","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0030","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1086\/524751","article-title":"US civilian smallpox preparedness and response program, 2003","volume":"46","author":"Strikas","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0035","first-page":"RR-10","article-title":"Vaccinia (smallpox) vaccine \u2013 recommendations of the advisory committee on immunization practices (ACIP)","volume":"50","author":"Centers for Disease Control and Prevention (CDC)","year":"2001","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0040","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/978-1-61779-876-4_1","article-title":"Working safely with vaccinia virus: laboratory technique and review of published cases of accidental laboratory infections. Vaccinia virus and poxvirology: methods and protocols, chapter 1","volume":"890","author":"Isaacs","year":"2012","journal-title":"Method Mol Biol"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0045","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/0140-6736(91)91093-A","article-title":"Accidental infection of laboratory worker with recombinant vaccinia virus","volume":"338","author":"Openshaw","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0050","first-page":"134","article-title":"Laboratory-acquired vaccinia infection","volume":"29","author":"Loeb","year":"2003","journal-title":"Can Commun Dis Rep"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0055","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1046\/j.1523-1747.2003.12074.x","article-title":"Laboratory acquired infection with recombinant vaccinia virus containing an immunomodulating construct","volume":"120","author":"Mempel","year":"2003","journal-title":"J Invest Dermatol"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0060","first-page":"724","article-title":"Accidental infection of laboratory worker with vaccinia virus","volume":"9","author":"Moussatch\u00e9","year":"2003","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0065","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3201\/eid1201.051126","article-title":"Ocular vaccinia infection in laboratory worker, Philadelphia, 2004","volume":"12","author":"Lewis","year":"2006","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0070","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.vaccine.2008.11.019","article-title":"Eczema vaccinatum resulting from the transmission of vaccinia virus from a smallpox vaccinee: an investigation of potential fomites in the home environment","volume":"27","author":"Lederman","year":"2009","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0075","doi-asserted-by":"crossref","first-page":"1555","DOI":"10.1086\/587668","article-title":"Severe eczema vaccinatum in a household contact of a smallpox vaccine","volume":"46","author":"Vora","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"19","key":"10.1016\/j.vaccine.2013.08.023_bib0080","first-page":"532","article-title":"Progressive vaccinia in a military smallpox vaccine \u2013 United States, 2009","volume":"58","author":"Centers for Disease Control and Prevention (CDC)","year":"2009","journal-title":"Morb Mortal Wkly Rep"},{"issue":"2","key":"10.1016\/j.vaccine.2013.08.023_bib0085","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.antiviral.2011.08.018","article-title":"Zoonotic Brazilian vaccinia virus: from field to therapy","volume":"92","author":"Kroon","year":"2011","journal-title":"Antivir Res"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0090","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/104063871002200132","article-title":"An outbreak of orthopoxvirus-associated disease in horses in southern Brazil","volume":"22","author":"Brum","year":"2010","journal-title":"J Vet Diagn Invest"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0095","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1006\/viro.2000.0603","article-title":"An emergent poxvirus from humans and cattle in Rio de Janeiro State: cantagalo virus may derive from Brazilian smallpox vaccine","volume":"277","author":"Damaso","year":"2000","journal-title":"Virology"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0100","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1590\/S0036-46652004000600004","article-title":"Human vaccinia-like v\u00edrus outbreaks in S\u00e3o Paulo and Goi\u00e1s States Brazil: virus detection, isolation and identification","volume":"46","author":"Nagasse-Sugahara","year":"2004","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0105","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1007\/s00705-010-0675-3","article-title":"Seroprevalence of orthopoxvirus in an Amazonian rural village, Acre, Brazil","volume":"155","author":"Mota","year":"2010","journal-title":"Arch Virol"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0110","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.vaccine.2011.09.105","article-title":"Human and animal infections by vaccinia-like viruses in the state of Rio de Janeiro: a novel expanding zoonosis","volume":"29","author":"Schatzmayr","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0115","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3201\/eid1801.110692","article-title":"Vaccinia virus zoonotic infection, Sao Paulo State, Brazil","volume":"18","author":"Megid","year":"2012","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0120","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1128\/JCM.41.7.3154-3157.2003","article-title":"Improved assay to detect neutralizing antibody following vaccination with diluted or undiluted vaccinia (Dryvax) vaccine","volume":"41","author":"Newman","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0125","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination","volume":"9","author":"Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0130","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1128\/CDLI.12.4.520-524.2005","article-title":"Persisting humoral antiviral immunity within the Japanese population after the discontinuation in 1976 of routine smallpox vaccinations","volume":"12","author":"Hatakeyama","year":"2005","journal-title":"Clin Diagn Lab Immunol"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0135","doi-asserted-by":"crossref","first-page":"2955","DOI":"10.1099\/vir.0.81265-0","article-title":"Prevalence of antibodies to vaccinia virus after smallpox vaccination in Italy","volume":"86","author":"Putz","year":"2005","journal-title":"J Gen Virol"},{"key":"10.1016\/j.vaccine.2013.08.023_bib0140","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.micinf.2005.02.004","article-title":"Activity of vaccinia-virus-neutralizing antibody in the sera of smallpox vaccines","volume":"7","author":"Viner","year":"2005","journal-title":"Microbes Infect"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X13011146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,2]],"date-time":"2020-08-02T07:22:29Z","timestamp":1596352949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X13011146"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10]]},"references-count":28,"journal-issue":{"issue":"42","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S0264410X13011146"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.023","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neutralizing antibodies associated with exposure factors to Orthopoxvirus in laboratory workers","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2013.08.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}